CA
NZ
UK
AU
IND
US
Heron Therapeutics, Inc. filed a DEFA14A with the SEC on November 9, 2026, disclosing preliminary communications related to a proposed transaction in which the company will sell substantially all of its assets to CorMedix Inc. under an Asset Purchase Agreement dated November 8, 2026.
Director Tenee R. Casaccio of Arrow Financial Corp filed a Form 4 on November 9, 2026, disclosing two transactions in common stock on November 5, 2026, involving the exercise of director stock options and a related share withholding.
Director Dayton Judd filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 17,888 shares of Lifevantage Corp common stock on November 5, 2026, under the company's outside director compensation program.
Director Raymond B. Greer filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 17,888 shares of Lifevantage Corp common stock on November 5, 2026, under the company's outside director compensation program.
Director Darwin Lewis filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 17,888 shares of Lifevantage Corp common stock on November 5, 2026, under the company's outside director compensation program.
Director Michael A. Beindorff filed a Form 4 with the SEC on November 9, 2026, disclosing the acquisition of 17,888 shares of Lifevantage Corp common stock on November 5, 2026, under the company's outside director compensation program.
Director Anbalagan Rajendran filed a Form 4 with the SEC on November 9, 2026, reporting the acquisition of 17,888 shares of Lifevantage Corp common stock on November 5, 2026, under the company's outside director compensation program.
Douglas G. Bergeron and affiliated reporting persons filed Amendment No. 2 to their beneficial ownership statement for Ethan Allen Interiors Inc. (NYSE:ETD) on November 9, 2026, disclosing that three DGB Investment director nominees were elected to the company's board at the November 4, 2026 …
Babcock & Wilcox Enterprises, Inc. filed its quarterly report on Form 10-Q with the SEC for the quarterly period ended September 30, 2026, disclosing financial results, capital structure changes, and ongoing risk factors for the industrial energy technology company listed on the NYSE.
An amended ownership statement for Alexander De Bock, Chief Financial Officer of Lucid Group, Inc., was filed on November 9, 2026, correcting the share amount reported in an original filing dated August 7, 2026, for a transaction that occurred on August 5, 2026.
Please wait processing your request...